Skip to content
10-K

Annual Report

ACTAVIA LIFE SCIENCES, INC.

0001213900-24-001370

← back to feed
Filed
Jan 5, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jan 4, 2024 771.81M sh
Shares Diluted FY 2023 · Sep 30, 2023 578.02M sh
Shares Diluted FY 2023 · Sep 30, 2022 111.43M sh
Operating Cash Flow FY 2023 · Sep 30, 2023 −$8.52K
Operating Cash Flow FY 2023 · Sep 30, 2022 −$312.66K
Stockholders Equity FY 2023 · Sep 30, 2023 −$1.96M
Stockholders Equity FY 2023 · Sep 30, 2022 −$1.69M
Current Liabilities FY 2023 · Sep 30, 2023 $2.05M
Current Liabilities FY 2023 · Sep 30, 2022 $1.68M
Total Liabilities FY 2023 · Sep 30, 2023 $2.05M
Total Liabilities FY 2023 · Sep 30, 2022 $1.77M
Total Assets FY 2023 · Sep 30, 2023 $95.66K
Total Assets FY 2023 · Sep 30, 2022 $85.28K
Eps Diluted FY 2023 · Sep 30, 2023 −$0.01
Eps Diluted FY 2023 · Sep 30, 2022 −$0.01
Eps Basic FY 2023 · Sep 30, 2023 −$0.01
Eps Basic FY 2023 · Sep 30, 2022 −$0.01
Sga Expense FY 2023 · Sep 30, 2023 $287.37K
Sga Expense FY 2023 · Sep 30, 2022 $300.07K
Rd Expense FY 2023 · Sep 30, 2023 $92.25K
Rd Expense FY 2023 · Sep 30, 2022 $83.84K
Net Income FY 2023 · Sep 30, 2023 −$4.44M
Net Income FY 2023 · Sep 30, 2022 −$686.59K
Operating Income FY 2023 · Sep 30, 2023 −$4.24M
Operating Income FY 2023 · Sep 30, 2022 $141.09K